STEM_OUT_1 [2025-04-17 10:42:13 -0400] 3939 Bytes | 1027 tokens | Cum: 1027 tkns (12.84% of 8k)
==========================================================================

Booyah, my friends! It's already 10:42:11 AM on Thu Apr 17, 2025 -0400, and I've got my eyes locked on Stem (STEM), pushing up to 0.3574 from 0.2948. Are we in for a serious bull run, or is this just hype? I've pulled the data—let's break it down!

--- COMPANY PROFILE ---
Company: Stem (STEM)
IPO: 2021-04-29 (3 Years Ago)
Market Cap: $55,088,647
Shares Outstanding: 164,150,000
Industry: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES
Exchange: XNYS
Description: Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.

Here’s a list of headlines for Stem:

Apr-08-25 08:30AM - Stem Announces First Quarter 2025 Results Conference Call
Mar-25-25 12:33PM - Stem Drops 13% in a Month: Are the Shares Worth Buying on the Dip?
Mar-18-25 08:30AM - Stem Appoints Software and Finance Veterans to Board of Directors
Mar-04-25 04:06PM - Stems PowerTrack Standard on Summit Ridge Energys 514 MW Commercial Solar Portfolio
Mar-04-25 04:06PM 04:05PM - Stem Announces Fourth Quarter and Full Year 2024 Results
Feb-25-25 10:00AM - Stem, Inc. (STEM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Feb-19-25 08:30AM - Stem Announces Fourth Quarter and Full-Year 2024 Earnings Results Conference Call
Feb-14-25 09:35AM - Down -22.89% in 4 Weeks, Here's Why Stem (STEM) Looks Ripe for a Turnaround

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2024-05-18T09:50:00Z - 3 Artificial Intelligence (AI) Stocks That Could Go Parabolic
B2 - 2024-04-30T14:01:06Z - Will Upstart Holdings, Inc. (UPST) Report Negative Earnings Next Week? What You Should Know
B3 - 2024-04-25T14:01:50Z - Stem, Inc. (STEM) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
B4 - 2024-03-26T00:30:00Z - Is Reddit Really Like Pinterest?
B5 - 2024-03-21T18:39:11Z - Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
B6 - 2024-03-21T17:58:07Z - Guess? Posts Upbeat Earnings, Joins Lufax, Nortech Systems And Other Big Stocks Moving Higher On Thursday

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Stem (STEM).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

STEM_OUT_3 [2025-04-17 10:42:14 -0400] 707 Bytes | 190 tokens | Cum: 1219 tkns (15.24% of 8k)
==========================================================================

Showing B3 (chunk 1 of 1): B3:
**Stem, Inc. (STEM) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release**Date: Unknown DateSource: Unknown SourceURL: https://www.zacks.com/stock/news/2262407/stem-inc-stem-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q1-releaseStem (STEM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

STEM_OUT_5 [2025-04-17 10:42:15 -0400] 1002 Bytes | 276 tokens | Cum: 1497 tkns (18.71% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-17T14:33:40Z - ADIO and DoH partner with ADSCC, NYU Abu Dhabi and UAEU to advance life sciences R&D in new Health, ...
A2 - 2025-04-17T14:29:15Z - Fake injury rule approved. If medical staff tends to player after ball is spotted, timeout charged...
A3 - 2025-04-17T14:32:09Z - Fake injury rule approved. If medical staff tends to player after ball is spotted, timeout charged...
A4 - 2025-04-17T14:38:44Z - Fake injury rule approved. If medical staff tends to player after ball is spotted, timeout charged...
A5 - 2025-04-17T14:37:19Z - Toronto's Trusted Web Design Agency for High-Impact Digital Solutions...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

STEM_OUT_7 [2025-04-17 10:42:15 -0400] 1181 Bytes | 322 tokens | Cum: 1821 tkns (22.76% of 8k)
==========================================================================

Showing A1 (chunk 1 of 8): A1:
**ADIO and DoH partner with ADSCC, NYU Abu Dhabi and UAEU to advance life sciences R&D in new Health, endurance, longevity, and medicine (HELM) cluster**Date: 2025-04-17Source: {'uri': 'zawya.com', 'dataType': 'news', 'title': 'Zawya.com'}URL: https://www.zawya.com/en/press-release/events-and-conferences/adio-and-doh-partner-with-adscc-nyu-abu-dhabi-and-uaeu-to-advance-life-sciences-r-and-d-in-new-health-endurance-longevity-and-medicine-helm-cluster-mks8htxsStrategic partnership to fast-track biomedical innovation and position Abu Dhabi as a leader in life sciences research

Abu Dhabi, UAE: The Abu Dhabi Investment Office (ADIO) and the Department of Health - Abu Dhabi (DoH) have signed a strategic agreement with the Abu Dhabi Stem Cells Centre (ADSCC), New York University Abu Dhabi (NYUAD) and UAE University to accelerate the development of the emirate's new Health, Endurance, Longe

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

STEM_OUT_9 [2025-04-17 10:42:16 -0400] 1181 Bytes | 274 tokens | Cum: 2097 tkns (26.21% of 8k)
==========================================================================

Showing A1 (chunk 2 of 8): vity, and Medicine (HELM) cluster.

The HELM cluster is a groundbreaking initiative spearheaded by the Abu Dhabi Department of Economic Development (ADDED), ADIO and DoH that aims to position Abu Dhabi as a global hub for biotechnology, MedTech and digital health innovation. The cluster is projected to contribute over AED 94 billion to Abu Dhabi's GDP and unlock 30,000 new jobs by 2045.

Announced during Abu Dhabi Global Health Week (ADGW), the partnership unites prominent Abu Dhabi-based research, academic and clinical institutions to commit resources, expertise and infrastructure to establish the HELM cluster as a pioneering innovation hub that promotes cutting-edge research and development (R&D), commercialisation and new opportunities for growth in the academic and private sectors.

H.E. Dr Noura Khamis Al Ghaithi, Undersecretary of the Department of Health - Abu Dhabi, commented: "A

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

STEM_OUT_11 [2025-04-17 10:42:17 -0400] 1181 Bytes | 237 tokens | Cum: 2336 tkns (29.20% of 8k)
==========================================================================

Showing A1 (chunk 3 of 8): bu Dhabi is not just investing in science, we are shaping the future of health. With the HELM cluster, we are bridging research, regulation and real-world impact to create an ecosystem where innovation thrives and transforms lives. This partnership reinforces Abu Dhabi's position as a leading global life sciences cluster, one that attracts talent, enables breakthrough discoveries, and powers a sustainable, knowledge-based economy."

As part of the agreement, all parties will work together to develop a comprehensive, clear and efficient framework to support advanced life sciences and biotechnology companies and academic institutions operating within the HELM cluster. This framework will facilitate their ability to commercialise products and services and integrate into global value chains while removing unnecessary barriers to innovation, while the DoH will ensure regulatory compliance.

H

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

STEM_OUT_13 [2025-04-17 10:42:19 -0400] 1181 Bytes | 255 tokens | Cum: 2593 tkns (32.41% of 8k)
==========================================================================

Showing A1 (chunk 4 of 8): .E. Badr Al-Olama, Director General of ADIO, said: "Abu Dhabi is advancing its role as a trusted destination for innovation, creating the conditions for globally impactful research to thrive. This agreement brings together the emirate's strongest academic, clinical and regulatory institutions to build an ecosystem where medical breakthroughs can move from research to real-world application faster, and at scale. With the HELM cluster, we are creating an environment where companies can innovate with confidence, access global markets and contribute to a life sciences ecosystem that's built for the future."

All parties will share laboratory networks and research infrastructure to enhance the scope and quality of research capabilities and output across the cluster.

H.E. Prof. Ahmed Ali Al Raeesi, Acting Vice Chancellor of the United Arab Emirates University, noted: "UAEU is the nation's fla

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

STEM_OUT_15 [2025-04-17 10:42:19 -0400] 1181 Bytes | 248 tokens | Cum: 2843 tkns (35.54% of 8k)
==========================================================================

Showing A1 (chunk 5 of 8): gship university, and in line with its strategic vision, it is committed to leadership, excellence and fostering knowledge that achieves a clear national impact. Collaborating with this distinguished group of experts provides us the opportunity to broaden our research excellence in key areas and prepare our students to lead the evolving medical sector."

Prof. Yendry Ventura, Chief Executive Officer of Abu Dhabi Stem Cells Center (ADSCC), stated: "As a leading R&D centre in cellular therapy, ADSCC's strength lies in translating scientific discovery into real-world therapies -- driven by an elite group of scientists and clinicians from bench to bedside. Through this collaboration, we are expanding our reach, deepening our partnerships and advancing Abu Dhabi's ambition to be at the forefront of medical innovation."

In parallel, the collaboration places a strong emphasis on talent develop

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

STEM_OUT_17 [2025-04-17 10:42:20 -0400] 1181 Bytes | 244 tokens | Cum: 3089 tkns (38.61% of 8k)
==========================================================================

Showing A1 (chunk 6 of 8): ment. The entities will collaborate on the development of specialised training programmes, internships and workshops to develop local talent in the life sciences field. Collaboration between academic institutions and the private sector will further enhance the cluster, with plans to create joint degree programmes, research fellowships and postdoctoral positions focused on human health research.

Fabio Piano, Vice Chancellor of NYU Abu Dhabi, said: "This partnership builds on our long-standing collaborations and sets the stage for more significant progress and breakthroughs. At NYU Abu Dhabi, we believe in the power of long-term commitments and global talent attraction and retention to drive progress in human health research and make a positive impact on the future of the UAE. Together, we're enhancing our connectivity, where ideas can grow and impact on a healthy future can take shape."

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

STEM_OUT_19 [2025-04-17 10:42:21 -0400] 1181 Bytes | 242 tokens | Cum: 3333 tkns (41.66% of 8k)
==========================================================================

Showing A1 (chunk 7 of 8):
This strategic alliance marks a significant step forward in the cluster's development, further strengthening Abu Dhabi's position as a global leader in scientific innovation, healthcare advancement and knowledge-based economic growth.

Held under the theme 'Towards Longevity: Redefining Health and Well-being', Abu Dhabi Global Health Week is a major government initiative from Department of Health - Abu Dhabi (DoH) to serve as a platform for innovation and collaboration within Abu Dhabi's healthcare sector.

About the Abu Dhabi Investment Office (ADIO):

The Abu Dhabi Investment Office (ADIO) is the government vehicle responsible for accelerating Abu Dhabi's growth and enabling the emirate's economic transformation. Through comprehensive support services, ADIO enables both local and foreign investors to shape industries of the future set to transform liveability, technology, resources an

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

STEM_OUT_21 [2025-04-17 10:42:22 -0400] 699 Bytes | 157 tokens | Cum: 3492 tkns (43.65% of 8k)
==========================================================================

Showing A1 (chunk 8 of 8): d value-added services. Initiatives focused on regional tourism and retail development, as well as public-private partnerships, ensure that community well-being is at the centre of Abu Dhabi's economic transformation. With a robust network of investors, strong collaboration with key stakeholders and a global presence, ADIO is committed to empowering those who invest with Abu Dhabi to make a lasting global impact.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

STEM_OUT_23 [2025-04-17 10:42:23 -0400] 1074 Bytes | 276 tokens | Cum: 3770 tkns (47.12% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-04-14 8-K ITEM9.01 Fin Stmnts and Exhibits

99 Email to Employees 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). Cautionary Statement Regarding Forward-Looking Stmnts

This Curr Report on Form 8-K contains forward-looking statements with...

S9 - 2025-03-04 10-K ITEM 7. MGT DISC & ANALYSIS OF FIN COND & RESULTS OF OPER

You should read the following managements discussion and analysis of our financial condition and results of operations (MDA) in conjunction with our CONS financial statements a...

S10 - 2025-03-04 8-K Item 2.02. Results of Oper and Fin Cond.

On March 4, 2025, Stem, Inc. (the Company) issued a press release announcing its financial results for the fourth quarter and full year 2024. The press release has been posted on the Companys internet website at https:/...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

STEM_OUT_25 [2025-04-17 10:42:24 -0400] 1181 Bytes | 273 tokens | Cum: 4045 tkns (50.56% of 8k)
==========================================================================

Showing S1 (chunk 1 of 4): S1:
ITEM9.01 Financial Statements and Exhibits

99 Email to Employees 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). Cautionary Statement Regarding Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Specific forward-looking statements include, without limitation, statements related to (i) the Companys intentions to prioritize investments in software, reduce operating costs, increase efficiency, drive profitable growth and increase stockholder value; (ii) the Companys expectations with respect to the Plan; (iii) the Companys estimates related to timing, cost and number of separations, one-time severance payments, and post-employment benefits; (iv) the Companys expect

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

STEM_OUT_27 [2025-04-17 10:42:26 -0400] 1181 Bytes | 248 tokens | Cum: 4295 tkns (53.69% of 8k)
==========================================================================

Showing S1 (chunk 2 of 4): ations related to future cash expenditures, including the factors and assumptions underlying the Companys expectations; (v) the Companys expectations with respect to savings associated with the Plan; and (vi) the Companys financial and operational outlook, expectations, goals, plans, targets, and projected results of operations, and including factors and assumptions underlying the Companys expectations and projections. These forward-looking statements are based on the Companys current estimates, intentions, beliefs, expectations, goals, strategies, and projections for the future and are not guarantees of future performance. Forward-looking statements

involve risks, uncertainties, assumptions, and other factors that are difficult to predict and that could cause actual results or outcomes to vary materially from those expressed in or indicated by them. Factors include, among others, (i)

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

STEM_OUT_29 [2025-04-17 10:42:26 -0400] 1181 Bytes | 249 tokens | Cum: 4546 tkns (56.83% of 8k)
==========================================================================

Showing S1 (chunk 3 of 4): the Companys ability to timely and effectively prioritize its initiatives and focus areas and related expenditures; (ii) the risk that the restructuring costs and charges may be greater than anticipated; (iii) the risk that the Companys restructuring efforts may adversely affect the Companys ability to recruit and retain sufficient numbers of qualified and motivated employees with appropriate skills and expertise to effectively and efficiently maintain its operations and execute the Companys plans, strategies, and initiatives; (iv) the risk that the Companys restructuring efforts may negatively impact the Companys strategy execution, business operations and reputation with or ability to serve customers; (v) the risk that the Companys restructuring efforts may not generate their intended benefits to the extent or as quickly as anticipated; and (vi) other factors, as described in the Compa

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

STEM_OUT_31 [2025-04-17 10:42:28 -0400] 894 Bytes | 195 tokens | Cum: 4743 tkns (59.29% of 8k)
==========================================================================

Showing S1 (chunk 4 of 4): nys filings with the Securities and Exchange Commission, including the detailed factors discussed under the heading Risk Factors in the Companys Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Forward-looking statements should be considered in light of these risks and uncertainties. Investors and others are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements contained herein speak only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law....

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

STEM_OUT_33 [2025-04-17 10:42:35 -0400] 7976 Bytes | 2136 tokens | Cum: 6881 tkns (86.01% of 8k)
==========================================================================

This is our set of metrics for Stem.
Please analyze the numbers.

+-------------------+-----------------------+-------------------------+------------------------+
| Volume: 3,754,896 | Perf Month: -21.50% | Option/Short: Yes / Yes | Sales Y/Y TTM: -68.67% |
+-------------------+-----------------------+-------------------------+------------------------+
| Avg Volume: 5.58M | Perf Quarter: -48.40% | Short Float: 25.84% | ROE: -6139.13% |
+-------------------+-----------------------+-------------------------+------------------------+
| Rel Volume: 3.61 | Index: RUT | Short Ratio: 7.14 | ROI: -467.92% |
+-------------------+-----------------------+-------------------------+------------------------+
| RSI (14): 47.24 | Market Cap: 59.87M | Short Interest: 39.87M | Sales Surprise: 16.53% |
+-------------------+-----------------------+-------------------------+------------------------+
| ATR (14): 0.05 | Shs Outstand: 162.80M | Beta: 1.54 | EPS Surprise: -58.43% |
+-------------------+-----------------------+-------------------------+------------------------+
| SMA20: 0.43% | Shs Float: 154.29M | Sales Q/Q: -66.66% | P/E: - |
+-------------------+-----------------------+-------------------------+------------------------+
| SMA50: -17.54% | Inst Own: 32.45% | Sales past 5Y: 78.85% | Earnings: Apr 29 AMC |
+-------------------+-----------------------+-------------------------+------------------------+
| SMA200: -37.91% | Insider Own: 7.15% | Employees: 569 | |
+-------------------+-----------------------+-------------------------+------------------------+
| Perf Week: 7.39% | Insider Trans: -0.57% | Debt/Eq: - | |
+-------------------+-----------------------+-------------------------+------------------------+

The next section covers any insider trading by Stem officers or majority shareholders (if available).

No transactions recorded.

No transactions recorded.

Inside Trans: STEM, INC. (STEM) by Shivram Krishna (Unknown Title) on 2025-03-17
- Restricted Stock Unit: 62222 shares at $0 (D)

Inside Trans: STEM, INC. (STEM) by Guruswamy Vasudevan (Unknown Title) on 2025-03-17
- Restricted Stock Unit: 62222 shares at $0 (D)

Inside Trans: STEM, INC. (STEM) by Carlson Michael James (Chief Operating Officer) on 2025-03-11
- Common Stock, Par Value $0.0001 Per Share: 70834 shares at $0 (D)
- Common Stock, Par Value $0.0001 Per Share: 27739 shares at $0.404 (D) Footnote: Represents shares of common stock automatically sold to cover the reporting person's tax liability in connection with the settlement of RSUs. This "sell to cover" transaction does not represent a discretionary trade by the reporting person.
- Restricted Stock Unit: 70834 shares at $0 (D)

Inside Trans: STEM, INC. (STEM) by Laureles Saul R. (Chief Legal Officer) on 2025-03-06
- Common Stock, Par Value $0.0001 Per Share: 18087 shares at $0 (D)
- Common Stock, Par Value $0.0001 Per Share: 58334 shares at $0 (D)
- Restricted Stock Unit: 18087 shares at $0 (D)
- Restricted Stock Unit: 58334 shares at $0 (D)

Inside Trans: STEM, INC. (STEM) by Tappin Matthew (President, Software Division) on 2025-03-06
- Common Stock, Par Value $0.0001 Per Share: 13397 shares at $0 (D)
- Common Stock, Par Value $0.0001 Per Share: 5645 shares at $0.419 (D) Footnote: Represents shares of common stock automatically sold to cover the reporting person's tax liability in connection with the settlement of RSUs. This "sell to cover" transaction does not represent a discretionary trade by the reporting person.
- Common Stock, Par Value $0.0001 Per Share: 29167 shares at $0 (D)
- Common Stock, Par Value $0.0001 Per Share: 13070 shares at $0.404 (D) Footnote: Represents shares of common stock automatically sold to cover the reporting person's tax liability in connection with the settlement of RSUs. This "sell to cover" transaction does not represent a discretionary trade by the reporting person.
- Restricted Stock Unit: 13397 shares at $0 (D)
- Restricted Stock Unit: 29167 shares at $0 (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 144584000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -854014000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.3574
Average Volume: 2703113.39
30-Day High: 0.459
30-Day Low: 0.2948

[Detailed Financials: TTM 2024]
- Total Assets: $437,359,000.0
- Total Liabilities: $835,192,000.0
- Total Equity: $-397,833,000.0
- Current Assets: $136,617,000.0
- Current Liabilities: $128,800,000.0

[Income Statement: TTM 2024]
- Revenue: $144,584,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -5.29

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $-48,390,000.0

[Detailed Financials: FY 2024]
- Total Assets: $437,359,000.0
- Total Liabilities: $835,192,000.0
- Total Equity: $-397,833,000.0
- Current Assets: $136,617,000.0
- Current Liabilities: $128,800,000.0

[Income Statement: FY 2024]
- Revenue: $144,584,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -5.29

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $-48,390,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Stem (STEM).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Stem.

2) MARKET_SCORE[]
This conversation was initiated because STEM is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for STEM.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, STEM could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect STEM to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Stem.

11) ETHICAL_RATING[]
Rate Stem’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Stem.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

STEM_IN_35 [2025-04-17 10:42:35 -0400] 126 Bytes | 29 tokens | Cum: 7145 tkns (89.31% of 8k)
==========================================================================

====================================
[2025-04-17 10:42:35] # Analysis Completed
Elapsed Time: 24.09 seconds